Sunshine Biopharma (NASDAQ: SBFM) has announced that its wholly owned Canadian subsidiary, Nora Pharma, has launched Pravastatin—a generic prescription version of the drug Pravachol.
Pravastatin is a statin medication that lowers low-density lipoprotein (LDL) and increases high-level lipoprotein (HDL) in the blood, helping to prevent heart attacks, strokes, and other cardiovascular conditions.
In a statement, Steve Slilaty, CEO of Sunshine, commented, “We are excited to introduce Pravastatin to the market. This launch reinforces our dedication to improving patient outcomes through innovative therapies that address critical health needs.”
